| Stage | MCHP | % of rev | NVDA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.5B | 100.00% | $96.2B | 100.00% | NVDA ×64.81 |
| Gross profit | $939M | 63.24% | $72.1B | 74.98% | NVDA +11.7pp |
| Operating income | $337M | 22.68% | $63.7B | 66.24% | NVDA +43.6pp |
| Pre-tax income | $290M | 19.53% | $71.5B | 74.32% | NVDA +54.8pp |
| Net income | $230M | 15.48% | $59.7B | 62.03% | NVDA +46.6pp |
| Stage | MCHP | NVDA | Gap · A − B |
|---|---|---|---|
| Revenue | $1.5B100.00% | $96.2B100.00% | NVDA ×64.81 |
| Gross profit | 63.24%$939M | 74.98%$72.1B | NVDA +11.7pp |
| Operating income | 22.68%$337M | 66.24%$63.7B | NVDA +43.6pp |
| Pre-tax income | 19.53%$290M | 74.32%$71.5B | NVDA +54.8pp |
| Net income |
| 15.48%$230M |
| 62.03%$59.7B |
| NVDA +46.6pp |